UBS AG - OREXIGEN THERAPEUTICS INC ownership

OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 129 filers reported holding OREXIGEN THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS AG ownership history of OREXIGEN THERAPEUTICS INC
ValueSharesWeighting
Q3 2014$521,000
-42.1%
122,382
-15.9%
0.00%
-100.0%
Q2 2014$900,000
-12.5%
145,496
-8.1%
0.00%0.0%
Q1 2014$1,029,000
+12.5%
158,308
-2.6%
0.00%0.0%
Q4 2013$915,000
+5.7%
162,500
+15.0%
0.00%0.0%
Q3 2013$866,000
-10.2%
141,350
-14.3%
0.00%0.0%
Q2 2013$964,000164,9770.00%
Other shareholders
OREXIGEN THERAPEUTICS INC shareholders Q3 2014
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 1$00.00%
View complete list of OREXIGEN THERAPEUTICS INC shareholders